TM
Tikvah Management’s Standard BioTools LAB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.06M | Sell |
5,051,058
-1,500,000
| -23% | -$1.8M | 1.95% | 15 |
|
2025
Q1 | $7.08M | Hold |
6,551,058
| – | – | 2.41% | 14 |
|
2024
Q4 | $11.5M | Hold |
6,551,058
| – | – | 3.12% | 10 |
|
2024
Q3 | $12.6M | Hold |
6,551,058
| – | – | 3.92% | 9 |
|
2024
Q2 | $11.6M | Hold |
6,551,058
| – | – | 3.78% | 9 |
|
2024
Q1 | $17.8M | Buy |
+6,551,058
| New | +$17.8M | 5.56% | 6 |
|
2022
Q1 | – | Sell |
-1,250,000
| Closed | -$4.9M | – | 25 |
|
2021
Q4 | $4.9M | Hold |
1,250,000
| – | – | 1.37% | 15 |
|
2021
Q3 | $8.24M | Hold |
1,250,000
| – | – | 2.23% | 12 |
|
2021
Q2 | $7.7M | Hold |
1,250,000
| – | – | 2.13% | 11 |
|
2021
Q1 | $5.65M | Hold |
1,250,000
| – | – | 1.58% | 11 |
|
2020
Q4 | $7.5M | Hold |
1,250,000
| – | – | 2.09% | 11 |
|
2020
Q3 | $9.29M | Hold |
1,250,000
| – | – | 2.87% | 10 |
|
2020
Q2 | $5.01M | Buy |
+1,250,000
| New | +$5.01M | 1.53% | 15 |
|